281 related articles for article (PubMed ID: 17193858)
41. Detection of cytomegalovirus infection by means of DNA isolated from paraffin-embedded tissues and dot hybridization.
Seto E; Yen TS
Am J Pathol; 1987 Jun; 127(3):409-13. PubMed ID: 3035929
[TBL] [Abstract][Full Text] [Related]
42. Corneal endotheliitis associated with evidence of cytomegalovirus infection.
Chee SP; Bacsal K; Jap A; Se-Thoe SY; Cheng CL; Tan BH
Ophthalmology; 2007 Apr; 114(4):798-803. PubMed ID: 17207531
[TBL] [Abstract][Full Text] [Related]
43. Evaluation of a novel real-time PCR system for cytomegalovirus DNA quantitation on whole blood and correlation with pp65-antigen test in guiding pre-emptive antiviral treatment.
Allice T; Cerutti F; Pittaluga F; Varetto S; Franchello A; Salizzoni M; Ghisetti V
J Virol Methods; 2008 Mar; 148(1-2):9-16. PubMed ID: 18045702
[TBL] [Abstract][Full Text] [Related]
44. Evaluation of an automated extraction system in combination with Affigene CMV Trender for CMV DNA quantitative determination: comparison with nested PCR and pp65 antigen test.
Abbate I; Finnstrom N; Zaniratti S; Solmone MC; Selvaggini S; Bennici E; Neri S; Brega C; Paterno M; Capobianchi MR
J Virol Methods; 2008 Jul; 151(1):61-5. PubMed ID: 18462815
[TBL] [Abstract][Full Text] [Related]
45. Quantification of cytomegalovirus viral load.
Pillet S; Roblin X; Cornillon J; Mariat C; Pozzetto B
Expert Rev Anti Infect Ther; 2014 Feb; 12(2):193-210. PubMed ID: 24341395
[TBL] [Abstract][Full Text] [Related]
46. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
[TBL] [Abstract][Full Text] [Related]
47. Comparison of a new Light Diagnostics and the CMV Brite to an in-house developed human cytomegalovirus antigenemia assay.
Percivalle E; Genini E; Chiesa A; Gerna G
J Clin Virol; 2008 Sep; 43(1):13-7. PubMed ID: 18468948
[TBL] [Abstract][Full Text] [Related]
48. Characteristics of cutaneous cytomegalovirus infection in non-acquired immune deficiency syndrome, immunocompromised patients.
Choi YL; Kim JA; Jang KT; Kim DS; Kim WS; Lee JH; Yang JM; Lee ES; Lee DY
Br J Dermatol; 2006 Nov; 155(5):977-82. PubMed ID: 17034528
[TBL] [Abstract][Full Text] [Related]
49. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis.
Kytö V; Vuorinen T; Saukko P; Lautenschlager I; Lignitz E; Saraste A; Voipio-Pulkki LM
Clin Infect Dis; 2005 Mar; 40(5):683-8. PubMed ID: 15714413
[TBL] [Abstract][Full Text] [Related]
50. Rapid immunodiagnosis of active cytomegalovirus infection by pp65 antigenemia assay.
Jahan M; Tabassum S; Islam MN
Bangladesh Med Res Counc Bull; 2006 Apr; 32(1):22-8. PubMed ID: 17665830
[TBL] [Abstract][Full Text] [Related]
51. Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome.
Asano Y; Kagawa H; Kano Y; Shiohara T
Arch Dermatol; 2009 Sep; 145(9):1030-6. PubMed ID: 19770444
[TBL] [Abstract][Full Text] [Related]
52. Clinical correlations of human cytomegalovirus strains and viral load in kidney transplant recipients.
Nogueira E; Ozaki KS; Tomiyama H; Câmara NO; Granato CF
Int Immunopharmacol; 2009 Jan; 9(1):26-31. PubMed ID: 18824137
[TBL] [Abstract][Full Text] [Related]
53. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
[TBL] [Abstract][Full Text] [Related]
54. Detection of cytomegalovirus infection by quantitative polymerase chain reaction.
Czader M; Post K; Cheng L
Methods Mol Biol; 2013; 999():257-71. PubMed ID: 23666705
[TBL] [Abstract][Full Text] [Related]
55. Monitoring of human cytomegalovirus glycoprotein B genotypes using real-time quantitative PCR in immunocompromised Chinese patients.
Fan J; Zhang X; Chen XM; Gao HN; Yang MF; Zhao H; Hu JH; Ma WH
J Virol Methods; 2009 Sep; 160(1-2):74-7. PubMed ID: 19406161
[TBL] [Abstract][Full Text] [Related]
56. Evaluation of human cytomegalovirus latency in alveolar macrophages.
Fajac A; Vidaud M; Lebargy F; Stephan F; Ricci S; Geslin P; Goossens M; Bernaudin JF
Am J Respir Crit Care Med; 1994 Feb; 149(2 Pt 1):495-9. PubMed ID: 8306052
[TBL] [Abstract][Full Text] [Related]
57. Multiple viral genome search in endolabyrinthic fluids of profoundly deaf patients: possible cytomegalovirus intracochlear reactivation.
Di Nardo W; Cattani P; Lopizzo T; Cantore I; Marchese MR; Marchetti S; Scorpecci A; Giannantonio S; Parrilla C; Cianfrone F; Fadda G; Paludetti G
Audiol Neurootol; 2009; 14(5):290-5. PubMed ID: 19372646
[TBL] [Abstract][Full Text] [Related]
58. [Detection of cytomegalovirus (CMV) DNA sequence in biopsy samples of cervical cancer].
Wang SF; Zhao Y; Fu QL; Yin MB; Liu YY
Zhonghua Zhong Liu Za Zhi; 1987 Jul; 9(4):279-81. PubMed ID: 2824151
[TBL] [Abstract][Full Text] [Related]
59. Real-time PCR assay compared with antigenemia assay for detecting cytomegalovirus infection in kidney transplant recipients.
Kim DJ; Kim SJ; Park J; Choi GS; Lee S; Kwon CD; Ki C; Joh J
Transplant Proc; 2007 Jun; 39(5):1458-60. PubMed ID: 17580161
[TBL] [Abstract][Full Text] [Related]
60. Cytomegalovirus DNA measurement in blood and plasma using Roche LightCycler CMV quantification reagents.
Tang W; Elmore SH; Fan H; Thorne LB; Gulley ML
Diagn Mol Pathol; 2008 Sep; 17(3):166-73. PubMed ID: 18382366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
